AcuityAds is undervalued ahead of Q2 results, Haywood says

AcuityAds CEO Tal Hayek.
Heading into the company’s second quarter results, Haywood Securities analyst Pardeep Sangha thinks there is money to be made on AcuityAds (TSXV:AT).

On August 14, after market close, AcuityAds will report its Q2, 2018 results. Sangha is modeling an Adjusted EBITDA loss of $200,000 on revenue of $11.5-million, a take that is in-line with the street consensus.

“We believe Acuity is undervalued,” Sangha says. “Acuity’s current share price offers a compelling entry point for investors given the Company has put the bad partners behind it, shored up its balance sheet and is experiencing growth organically and through acquisitions. Acuity is currently trading at 1.1x EV/Revenue of our CY18 estimates, which is lower than its peer group average which trades at 4.3x EV/Revenue of consensus CY18 estimates. Our target price represents 1.1x EV/Revenue multiple and 8.4x EV/EBITDA multiple of our CY19 forecast.”

In a research update to client today, Sangha maintained his “Buy” rating and one-year price target of $1.50 on AT, implying a return of 32.7 per cent at the time of publication.

Sangha thinks AcuityAds will generate Adjusted EBITDA of $2.0-million on revenue of $52.6-million in 2018.

The analyst detailed the key points he will be looking for from the quarter.

“On the conference call, we will be listening for: 1) updated guidance for Q3 and annual revenue growth; 2) improving gross margins and profitability in the second half of CY18; 3) cost synergies from ADman integration and future cross selling opportunities; 4) Update on M&A activity and pipeline,” he said.

Tagged with: at
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

BCE upgraded to “Buy” at TD

TD Cowen analyst Vince Valentini says the recent pullback in BCE (BCE Stock Quote, Chart, News, Analysts, Financials TSX:BCE) shares… [Read More]

1 day ago

This analyst just upgraded Versabank to “Buy”

Roth Capital Partners analyst Craig Irwin says VersaBank’s (VBNK Stock Quote, Chart, News, Analysts, Financials NASDAQ:VBNK) early commercial rollout of… [Read More]

1 day ago

This analyst just raised his price target on Rocket Lab USA

Roth Capital Partners analyst Suji Desilva says Rocket Lab USA’s (Rocket Lab USA Stock Quote, Chart, News, Analysts, Financials NASDAQ:RKLB)… [Read More]

2 days ago

Why this analyst just chopped his price target on Medicenna Therapeutics

Research Capital analyst Andre Uddin says Medicenna Therapeutics (Medicenna Therapeutics Stock Quote, Chart, News, Analysts, Financials TSX:MDNA) has upcoming clinical… [Read More]

2 days ago

Firan Technology: Buy, Sell or Hold?

Beacon Securities analyst Russell Stanley says Firan Technology Group’s (Firan Technology Group Stock Quote, Chart, News, Analysts, Financials TSX:FTG) new… [Read More]

2 days ago

Magellan Aerospace is still undervalued, this fund manager says

LionGuard Capital Management CEO and CIO Andrey Omelchak says Magellan Aerospace (Magellan Aerospcace Stock Quote, Chart, News, Analysts, Financials TSX:MAL)… [Read More]

4 days ago